Home > Financial Ratios > CONCORD DRUGS

CONCORD DRUGS
Fixed Capital/Sales

    Back to All Ratios
CONCORD DRUGS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD DRUGS
Please provide your vote to see the results

CONCORD DRUGS Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
   Fixed Capital/Sales(x) 0.850.550.470.62

What is the latest Fixed Capital/Sales ratio of CONCORD DRUGS ?

The latest Fixed Capital/Sales ratio of CONCORD DRUGS is 0.85 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.85
Mar20240.55
Mar20230.47
Mar20220.62

How is Fixed Capital/Sales of CONCORD DRUGS Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.85
54.55
Mar2024 0.55
17.02
Mar2023 0.47
-24.19
Mar2022 0.62 -

Other Financial Ratios of CONCORD DRUGS


Compare Fixed Capital/Sales ratio of peers of CONCORD DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD DRUGS ₹103.3 Cr 6.2% -1.4% 16.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,276.0 Cr -0.2% -3.2% 12.7% Stock Analytics
DIVIS LABORATORIES ₹251,531.0 Cr 2% 5.3% 57.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,957.0 Cr -2.4% -3.1% 36.4% Stock Analytics
CIPLA ₹111,729.0 Cr 0.6% -2.2% -9.4% Stock Analytics
DR REDDYS LABORATORIES ₹104,335.0 Cr 0.9% 4% -7.6% Stock Analytics


CONCORD DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD DRUGS

6.2%

-1.4%

16.9%

SENSEX

-2.7%

-5.7%

-11.7%


You may also like the below Video Courses